Skip to main navigation Skip to search Skip to main content

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

  • Nina Worel*
  • , Jarl E. Mooyaart
  • , Jorinde D. Hoogenboom
  • , Michael Daskalakis
  • , Jean Jacques Tudesq
  • , Ron Ram
  • , Vladan Vucinic
  • , Stefania Bramanti
  • , Lucía López Corral
  • , Emma Nicholson
  • , Robert Zeiser
  • , Friedrich Stölzel
  • , Eugenio Galli
  • , Simona Pagliuca
  • , Eva Wagner-Drouet
  • , Friso Calkoen
  • , Christian Chabannon
  • , Florent Malard
  • , Annalisa Ruggeri
  • , Jürgen Kuball
  • *Corresponding author for this work
  • Medical University of Vienna
  • EBMT Leiden Study Unit
  • University of Bern
  • CHU Montpellier
  • Tel Aviv Sourasky Medical Center
  • Leipzig University
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • Hospital Clínico Universitario de Salamanca
  • Royal Marsden NHS Foundation Trust
  • University of Freiburg
  • University Medical Center Schleswig- Holstein
  • Catholic University of Sacred Heart
  • CHU de Nancy
  • Johannes Gutenberg University Mainz
  • Utrecht University
  • Institut Paoli Calmettes
  • Sorbonne Université
  • IRCCS San Raffaele Scientific Institute

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)1184-1186
Number of pages3
JournalBone Marrow Transplantation
Volume60
Issue number8
DOIs
StatePublished - Aug 2025
Externally publishedYes

Funding

Funders
Kite
Gilead Sciences
Janssen and Gilead
Micropalaeontological Society
DSMB
Celgene

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 9 - Industry, Innovation, and Infrastructure
      SDG 9 Industry, Innovation, and Infrastructure

    Cite this